[Evaluation of the effectiveness of and tolerance to a new psychopharmacological agent in the anxiety-depression syndrome (comparison in a double-blind study with diazepam)].
D001007:Anxiety / Q000188:drug therapy*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use*; D004311:Double-Blind Method; D004361:Drug Tolerance; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D014196:Trazodone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
D010879:Piperazines; D003975:Diazepam; D014196:Trazodone
Valutazione dell'efficacia e della tollerabilità di un nuovo psicofarmaco nella sindrome ansioso-depressiva (confronto in doppio cieco versus diazepam).